All Stories

  1. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

    Article • ESMO Open, February 2019, BMJ

    Shigehira Saji

  2. A Case of Squamous Cell Carcinoma of Unknown Primary that Responded to the Multi-Tyrosine Kinase Inhibitor Lenvatinib

    Article • Case Reports in Oncology, February 2018, Karger Publishers

    Shigehira Saji